<?xml version="1.0" encoding="UTF-8"?>
<p>Although usually a self-limiting disease in immunocompetent persons, hepatitis E can cause serious complications in at-risk populations such as pregnant women [
 <xref rid="B17-pathogens-09-00856" ref-type="bibr">17</xref>] and organ transplant recipients [
 <xref rid="B5-pathogens-09-00856" ref-type="bibr">5</xref>,
 <xref rid="B18-pathogens-09-00856" ref-type="bibr">18</xref>,
 <xref rid="B19-pathogens-09-00856" ref-type="bibr">19</xref>]. Treatment options remain limited, and only one vaccine has been developed so far with its use limited to China [
 <xref rid="B20-pathogens-09-00856" ref-type="bibr">20</xref>].
</p>
